Douglas Loe
Stock Analyst at Leede Financial
(4.66)
# 816
Out of 4,592 analysts
152
Total ratings
47%
Success rate
22.4%
Average return
Main Sectors:
Stocks Rated by Douglas Loe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $22.48 | $14.00 | +60.56% | 3 | Mar 11, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $3.00 | $0.30 | +916.95% | 3 | Mar 8, 2026 | |
| TSXV: NSCI Nanalysis Scientific Corp. | Maintained: Buy | $0.50 | $0.13 | +300.00% | 1 | Nov 27, 2025 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $8.5 → $4 | $0.7533 | +431.00% | 18 | Nov 25, 2025 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $6.32 → $15.45 | $1.76 | +778.07% | 5 | Aug 8, 2025 | |
| PMN ProMIS Neurosciences | Maintained: Buy | n/a | $13.72 | n/a | 2 | Jul 22, 2025 | |
| TSX: DR Medical Facilities Corporation | Maintained: Buy | $4.50 → $15.50 | $17.46 | n/a | 7 | Aug 7, 2024 | |
| TSX: SVA Sernova Biotherapeutics Inc | Maintained: Buy | $3.30 → $4.64 | $0.11 | n/a | 9 | Jun 30, 2023 | |
| TSX: EXE Extendicare Inc. | Maintained: Hold | $8.25 → $7.00 | $35.48 | n/a | 13 | May 8, 2023 | |
| IMVIF IMV Inc. | Reiterated: Buy | $7.47 → $43 | $0.000001 | n/a | 18 | Apr 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $0.25 | $0.02 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 → $0.11 | $2.08 | n/a | 12 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.56 | $0.0001 | n/a | 13 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.00 | $3.63 | n/a | 12 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27.00 → $29.00 | $47.40 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $16.83 | n/a | 17 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37.50 | $10.38 | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $1 | $4.34 | n/a | 4 | Oct 7, 2019 |
Satellos Bioscience Inc.
Mar 11, 2026
Maintained: Buy
Price Target: $22.48
Current: $14.00
Upside: +60.56%
Perimeter Medical Imaging AI, Inc.
Mar 8, 2026
Reiterated: Buy
Price Target: $3.00
Current: $0.30
Upside: +916.95%
Nanalysis Scientific Corp.
Nov 27, 2025
Maintained: Buy
Price Target: $0.50
Current: $0.13
Upside: +300.00%
Oncolytics Biotech
Nov 25, 2025
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.7533
Upside: +431.00%
Cardiol Therapeutics Inc.
Aug 8, 2025
Maintained: Buy
Price Target: $6.32 → $15.45
Current: $1.76
Upside: +778.07%
ProMIS Neurosciences
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $13.72
Upside: n/a
Medical Facilities Corporation
Aug 7, 2024
Maintained: Buy
Price Target: $4.50 → $15.50
Current: $17.46
Upside: n/a
Sernova Biotherapeutics Inc
Jun 30, 2023
Maintained: Buy
Price Target: $3.30 → $4.64
Current: $0.11
Upside: n/a
Extendicare Inc.
May 8, 2023
Maintained: Hold
Price Target: $8.25 → $7.00
Current: $35.48
Upside: n/a
IMV Inc.
Apr 12, 2022
Reiterated: Buy
Price Target: $7.47 → $43
Current: $0.000001
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $2.75 → $0.25
Current: $0.02
Upside: n/a
Aug 31, 2020
Downgraded: Sell
Price Target: $1 → $0.11
Current: $2.08
Upside: n/a
Aug 27, 2020
Maintained: Buy
Price Target: $3.56
Current: $0.0001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $7.00
Current: $3.63
Upside: n/a
Aug 14, 2020
Maintained: Hold
Price Target: $27.00 → $29.00
Current: $47.40
Upside: n/a
Aug 13, 2020
Maintained: Buy
Price Target: $3.00
Current: $16.83
Upside: n/a
Aug 7, 2020
Maintained: Buy
Price Target: $37.50
Current: $10.38
Upside: n/a
Jun 16, 2020
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 7, 2019
Downgraded: Hold
Price Target: $34 → $1
Current: $4.34
Upside: n/a